Share

February 07, 2017; 88 (6) ArticleOpen Access

Acute plasma tau relates to prolonged return to play after concussion

Jessica Gill, Kian Merchant-Borna, Andreas Jeromin, Whitney Livingston, Jeffrey Bazarian
First published January 6, 2017, DOI: https://doi.org/10.1212/WNL.0000000000003587
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
5426

Share

Article Information

vol. 88 no. 6 595-602
DOI: 
https://doi.org/10.1212/WNL.0000000000003587
PubMed: 
28062722
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received May 20, 2016
  • Accepted in final form October 10, 2016
  • First Published January 6, 2017.

Article Versions

Copyright & Usage: 
Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. Jessica Gill, RN, PhD,
    2. Kian Merchant-Borna, MPH,
    3. Andreas Jeromin, PhD,
    4. Whitney Livingston, BA and
    5. Jeffrey Bazarian, MD, MPH
  1. Jessica Gill, RN, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH intramural research, year 2012-current

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Kian Merchant-Borna, MPH,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Andreas Jeromin, PhD,
    4. Scientific Advisory Boards:

    1. Quanterix Corp.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Founder and CSO, Atlantic Biomarkers, LLC Scientific and Medical Advsior, Quanterix, Inc.

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. Quanterix, Inc.

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. Banyan Biomarkers, Inc. (past) Quanterix. Corp.

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Whitney Livingston, BA and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Jeffrey Bazarian, MD, MPH
    6. Scientific Advisory Boards:

    1. BlackBox Biometrics-Scientific Advisory Board

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Journal of Head Trauma Rehabilitation-Editorial Advisory Board Member

    Patents:

    1. Provisional Patent ?System and Method to Assess Risk of Changes to Brain White Matter Based on Head Impact Dose Equivalent Number?. Filed 1.9.15 This patent involves a mathematical algorithm that relates weighted cumulative helmet accelerometer forces to changes in brain white matter on diffusion tensor imaging.

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Received honoraria for lectures or educational activities not funded by industry.

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. BrainScope Inc-research support

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. BrainScope Inc-research support

    Research Support, Government Entities:

    1. NIH 1K24HD064754, PI, 2011-2016 NCAA-DODContract Award: 3003497434, Site PI 2015-17

    Research Support, Academic Entities:

    1. NYS DOH, PI, 2008-2010

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. BlackBox Biometrics-50 Phantom Units of Equity Interest

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the National Institute of Nursing Research (J.G., W.L.), NIH, Bethesda, MD; Department of Emergency Medicine (K.M.-B., J.B.), University of Rochester School of Medicine and Dentistry, Rochester, NY; and Quanterix Corporation (A.J.), Lexington, MA.
  1. Correspondence to Dr. Gill: gillj{at}mail.nih.gov
View Full Text

Article usage

Article usage: January 2017 to October 2020

AbstractFullPdfSource
Jan 2017296071483Highwire
Feb 20172385220802Highwire
Feb 20170304pmc
Mar 2017566100436Highwire
Mar 201707327pmc
Apr 201736062248Highwire
Apr 2017143146pmc
May 201726178144Highwire
May 2017102930pmc
Jun 20171532977Highwire
Jun 2017274244pmc
Jul 20171104162Highwire
Jul 2017173740pmc
Aug 2017943376Highwire
Aug 2017142830pmc
Sep 2017837262Highwire
Sep 2017143835pmc
Oct 2017793878Highwire
Oct 2017183938pmc
Nov 20171185265Highwire
Nov 2017124050pmc
Dec 2017424839Highwire
Jan 2018736549Highwire
Feb 2018944497Highwire
Mar 2018873263Highwire
Apr 2018766480Highwire
Apr 201884549pmc
May 2018935458Highwire
Jun 2018626840Highwire
Jun 201893635pmc
Jul 2018514226Highwire
Aug 2018363040Highwire
Aug 201882125pmc
Sep 2018323343Highwire
Oct 2018404837Highwire
Nov 2018416347Highwire
Dec 2018453420Highwire
Jan 2019425648Highwire
Feb 2019206231Highwire
Mar 201947037Highwire
Apr 201917735Highwire
May 2019144154Highwire
Jun 2019104637Highwire
Jul 201984232Highwire
Aug 2019127646Highwire
Sep 2019115937Highwire
Oct 2019205757Highwire
Nov 2019216361Highwire
Dec 201995424Highwire
Jan 2020177633Highwire
Feb 2020196833Highwire
Mar 20201511931Highwire
Apr 202088026Highwire
May 2020612436Highwire
Jun 2020105627Highwire
Jul 202066416Highwire
Aug 202056222Highwire
Sep 202096434Highwire
Oct 202098844Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me